CareScreen Terms
Effective Date: January 1, 2025
These CareScreen Terms apply to CareScreen by FabrixMed Systems LLC ("FabrixMed", "we", "us", or "our"). They supplement the FabrixMed Terms of Service, Privacy Policy, HIPAA Notice, Acceptable Use Policy, and any signed agreement or BAA.
CareScreen was previously known as CarePlus. Current documents and customer communications should use CareScreen.
1. What CareScreen Is
CareScreen is a clinical screening workflow platform that helps healthcare organizations identify care gaps, collect structured screening information, support in-clinic or directed patient capture, route data for specialist review, and return documented results to the care team or medical record workflow.
CareScreen may support screening programs such as diabetic retinopathy, chronic kidney disease, HbA1c, blood pressure, preventive care, quality measure, and similar workflows. It is not a standalone EHR, medical device manufacturer, independent diagnostic service, payer, or direct-to-consumer healthcare service unless a signed agreement says otherwise.
2. Eligible Users
CareScreen is intended for healthcare organizations, primary care providers, authorized clinical staff, specialists, screening partners, and patients who are directed by their care team. Patients should not use CareScreen as a substitute for a provider relationship or urgent care.
3. Clinical Responsibility
CareScreen supports clinical workflows but does not replace professional judgment. The ordering or responsible provider remains responsible for selecting appropriate screenings, obtaining patient consent, reviewing results, communicating findings, arranging follow-up, documenting care, and making medical decisions.
Specialist reviews, automated prompts, quality measure outputs, and screening statuses are decision-support information. FabrixMed does not guarantee diagnosis, treatment outcome, quality score, HEDIS/STARS acceptance, payer reimbursement, or closure of any care gap.
4. PHI, Devices, and Integrations
CareScreen may process PHI, images, device data, lab values, screening responses, clinical notes, and demographic information. A BAA must be in place before production PHI is submitted.
Customers are responsible for device selection, local device operation, image quality, EHR configuration, patient consent, patient identity confirmation, and secure handling of data before and after it enters CareScreen.
5. Patient Participation
Patients may submit information only as part of a workflow directed by a healthcare provider or authorized organization. Patients should contact their care team for medical advice, abnormal results, record requests, or follow-up questions.
6. Payments and Program Terms
Fees, screening rates, specialist review fees, program scope, and payment terms are governed by the applicable order form, customer agreement, provider agreement, or checkout flow.
7. Prohibited Use
You may not use CareScreen to delay urgent care, submit false screening data, misrepresent quality measure performance, use unapproved devices or integrations, disclose PHI through unauthorized channels, or use the platform outside your authorized clinical role.
Questions can be sent to [email protected].